Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Internal Medicine (Tokyo, Japan)|November 2, 2020
Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C VirusTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Hepatology International|June 2, 2021
Bile extracellular vesicles from end-stage liver disease patients show altered microRNA contentSuguru Nakashiki, Satoshi Miuma, Hiroyuki Mishima, et al.
Trials|February 13, 2021
Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trialMasafumi Haraguchi, Kunihiro Ichinose, Hisamitsu Miyaaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 25, 2017
Hepatitis C virus-related symptoms, but not quality of life, were improved by treatment with direct-acting antiviralsTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Cancers|November 14, 2019
Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical SettingsRyu Sasaki, Masanori Fukushima, Masafumi Haraguchi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 26, 2024
Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, et al.
Anticancer Research|April 4, 2021
Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of LenvatinibRyu Sasaki, Masanori Fukushima, Masafumi Haraguchi, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2026
Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled TrialHiroki Inada, Toshinori Toyota, Haruki Uojima, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2025
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class BRyu Sasaki, Shigeo Shimose, Issei Saeki, et al.
Cancer Medicine|March 23, 2019
Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort studyMasahito Nakano, Hironori Koga, Tatsuya Ide, et al.
Pageof 13